Literature DB >> 35114888

Human Hepatocytes Isolated from Explanted Livers: A Powerful Tool to Understand End-stage Liver Disease and Drug Screening.

Lanuza A P Faccioli1, Zehra N Kocas-Kilicarslan1, Ricardo Diaz-Aragon1, Takashi Motomura1, Sriram Amirneni1, Michelle R Malizio1, Michael C Coard1, Carla Frau1, Nils Haep1, Rodrigo M Florentino1,2, Alina Ostrowska1,2.   

Abstract

The use of primary human hepatocytes has been hampered by limited availability of adequate numbers of fresh and viable cells due to the ongoing shortage of liver donors. Thus, there is no surplus of healthy organs from which freshly isolated cells can be prepared when needed. However, primary hepatocytes can be successfully isolated from explanted liver specimens obtained from patients receiving orthotopic liver transplantation for decompensated liver cirrhosis or for metabolic liver disease without end-stage liver disease and are a valuable resource for the pharmaceutical industry research. This review focuses on the isolation, characterization and cryopreservation of hepatocytes derived from therapeutically resected livers with various hepatic diseases.

Entities:  

Keywords:  Hepatocyte isolation; cryopreservation; diseased liver; drug screening

Mesh:

Year:  2021        PMID: 35114888      PMCID: PMC9208801          DOI: 10.1080/15476278.2021.1992216

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.316


  32 in total

Review 1.  General review on in vitro hepatocyte models and their applications.

Authors:  Christiane Guguen-Guillouzo; Andre Guillouzo
Journal:  Methods Mol Biol       Date:  2010

2.  A novel cannulation technique for isolation of human hepatocytes from explanted diseased whole livers.

Authors:  D C Kehr; N Raschzok; I M Sauer
Journal:  Transplant Proc       Date:  2012-05       Impact factor: 1.066

3.  Hypothermic storage of isolated human hepatocytes: a comparison between University of Wisconsin solution and a hypothermosol platform.

Authors:  Alina Ostrowska; Kenan Gu; Donald C Bode; Robert G Van Buskirk
Journal:  Arch Toxicol       Date:  2009-03-19       Impact factor: 5.153

4.  New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants.

Authors:  Roberto Gramignoli; Veysel Tahan; Kenneth Dorko; Kristen J Skvorak; Marc C Hansel; Wenchen Zhao; Raman Venkataramanan; Ewa C S Ellis; Carl Jorns; Bo-Goran Ericzon; Staffan Rosenborg; Raoul Kuiper; Kyle A Soltys; George V Mazariegos; Ira J Fox; Elizabeth M Wilson; Markus Grompe; Stephen C Strom
Journal:  Stem Cell Res       Date:  2013-03-27       Impact factor: 2.020

Review 5.  Human hepatocyte transplantation for liver disease: current status and future perspectives.

Authors:  V Iansante; R R Mitry; C Filippi; E Fitzpatrick; A Dhawan
Journal:  Pediatr Res       Date:  2017-12-06       Impact factor: 3.756

6.  Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience.

Authors:  Ricky H Bhogal; James Hodson; David C Bartlett; Christopher J Weston; Stuart M Curbishley; Emma Haughton; Kevin T Williams; Gary M Reynolds; Phillip N Newsome; David H Adams; Simon C Afford
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

Review 7.  Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury.

Authors:  Yitian Zhou; Joanne X Shen; Volker M Lauschke
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

Review 8.  Generation of functional human hepatocytes in vitro: current status and future prospects.

Authors:  Tomoko Yamaguchi; Juntaro Matsuzaki; Takeshi Katsuda; Yoshimasa Saito; Hidetsugu Saito; Takahiro Ochiya
Journal:  Inflamm Regen       Date:  2019-07-02

9.  Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes.

Authors:  Moritz Kleine; Marc Riemer; Till Krech; Daphne DeTemple; Mark D Jäger; Frank Lehner; Michael P Manns; Jürgen Klempnauer; Jürgen Borlak; Hueseyin Bektas; Florian W R Vondran
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

10.  Emerging trends in modeling human liver disease in vitro.

Authors:  Gregory H Underhill; Salman R Khetani
Journal:  APL Bioeng       Date:  2019-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.